About GOBIOM Biomarker
GOBIOM Biomarker is a company based in Hyderabad (India) founded in 2008. It operates as a B2B. GOBIOM Biomarker operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others.
- Headquarter Hyderabad, India
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$175.87 M (USD)0as on Mar 31, 2021
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GOBIOM Biomarker
Investments & Acquisitions by GOBIOM Biomarker
Financial Statements - GOBIOM Biomarker
Gobiom Biomarker Comparisons
Competitors of GOBIOM Biomarker
GOBIOM Biomarker operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Novel cancer drugs are developed using synthetic lethality screening.
|
|
| domain | founded_year | HQ Location |
AI-based data-mining tools for scientific evidence discovery are provided.
|
Latest news on Gobiom Biomarker
Frequently Asked Questions about GOBIOM Biomarker
GOBIOM Biomarker was founded in 2008.
GOBIOM Biomarker is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Annual revenue of GOBIOM Biomarker is $175.87M as on Mar 31, 2021.
GOBIOM Biomarker, established in 2008, excels in providing healthcare solutions, advancing biotech innovations, data services, and biomarker databases. Provides comprehensive solutions for biomarker database management and analysis. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
GOBIOM Biomarker's top competitors include Alector, Lexicon Pharmaceuticals and Maze Therapeutics.